Exenatide, dapagliflozin or phentermine/topiramate differentially affect metabolic profiles in polycystic ovary syndrome
Journal of Clinical Endocrinology and Metabolism | Jun 10, 2021
Journal of Clinical Endocrinology and Metabolism | Jun 10, 2021